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LETTERS TOTHE EDITOR
years in the closed commissurotomy group (n = i05)
. The preoper-
ative features were similar in both groups with respect to valve
involvement, subvalvular pathology and pulmonary artery pressures
(as predicted by echocardiography). The closed commissurotomy
group had a good result of valvotomy (mitral valve area, 2.3 t 0.52)
and compared favorably with the open commissurotomy group
(mitral valve area, 2 .52 t 0.56) (p = NS), and in all other variables
the two groups were similar . Mitral regurgitation occurred with
equal frequency in the groups with open and closed commissar
.
otomy (68% vs . 66%) although the group with tire closed procedure
had more patients with significant mitral regurgitation (9 .3% vs .
11 .3%) . In both groups mitral regurgitation occurred in patients with
more severe subvalvular fusion . Chordal tear, laceration and partial
tear of the papillary muscle, cusp avulsion were more often seen in
patients undergoing closed commissurotomy (9 .8%). All of these
patients had severe subvalvular fusion .
This is only a preliminary report and more detailed analysis and
follow-up are necessary before a definite conclusion can be reached .
However, we still believe that the closed procedure has a place
today, at least in financially indigent populations . The only watch
word is to choose the appropriate patient carefully .
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Diltiazem and Mortality in
Myocardial Infarction
In their review article, Bakris and Frohlich (I) state that the calcium
channel blacker dilliazem reduces mortality in patients with non
Q-wave myocardial infarction. The reference cited does not support
their view.
Compared with the established protective effects of a beta-
blacker in prolonging life and reducing recurrence of nonfatal
myocardial infarction in survivors of acute myocardial infarction,
none of the currently used calcium channel blockers (verapamil,
nifedipine, dilliazem) has been shown to be as favorable . Further-
more, a trial usingdiltiueem in patients with non Q-wave myocardial
infarction (2) (the reference cited by Bakris and Frohlich) showed no
reduction in mortality. Moreover, the Multicenter Diltiazem Postin
.
farctioe Trial (3) showed no difference in mortality between patient
groups. On the contrary, the subgroup of patients with left ventric-
ular dysfunction did worse with dilliazem
.
From the currently available data it may be concluded that the
prophylactic use of calcium channel blockers including dittiazem to
improve survival after myocardial infarction cannot be recom-
mended at this time
.
GEORGE BITTAR, MD
Deparnnem of Medicine
Sdwol of Medicine
Hunrington, West Virginia 25755
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Reply
Bittar is correct that the reference we cited did not present infor-
mation concerning deaths related to non-Q wave infarction in
patients with hypertension
. We included reference to the original
paper on the Multicenter Diltinzem Postinfaretion Trial because it
detailed the study design . Not included were details of a paper
whose data we heard presented at a national meeting
. We had
planned to cite that paper on the return of proofs to us, but it was not
yet published. The paper by Moss et al . (I) is now published
presenting data demonstrating an overall reduction in cardiac deaths
or nonfatal recurrent myocardial infarction in patients treated with
diltiazem, results not observed in placebo-treated patients or pa-
tients without a history of hypertension . We are pleased to add this
reference in support of our statement
. It underscores the sometimes
lengthy delay from presentation of new information to publication .
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